WORLD PEPTIDEFOUNDATION

Two fictional cases

The people and results below are invented for teaching. They are not real patients, and no value here is a target.

Fictional example

Taylor: two glucose reports

Taylor has two glucose reports. One sample followed an overnight fast. The other followed lunch. Taylor asks whether the second means glucose control changed.

Walk through

  1. Test names. Does each report say fasting, random, or only “glucose”?
  2. Units and laboratory. Are both in the same unit, from the same laboratory and method?
  3. Collection timing. Overnight fast versus after lunch are different circumstances, so the two numbers were not collected to answer the same question.
  4. Original reason for testing. Screening, symptoms and monitoring each lead to different comparisons.
  5. Context. Does an A1C or another result help describe the longer view?

Takeaway: Two glucose numbers are not automatically comparable. Timing and test type decide whether a change means anything.

Appointment question: “Were these results intended to be compared, and which should we use as a baseline?”

Fictional example

Jordan: a proposed monitoring plan

Jordan is discussing Egrifta WR with a clinician. Glucose and IGF-1 appear on the proposed monitoring plan. Jordan asks whether both show whether treatment works.

Walk through

  1. The label names glucose and IGF-1 monitoring because treatment can affect these markers (Sections 5.4 and 5.2). They are safety considerations in the label text.
  2. The label's indication is a reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. A monitoring instruction does not decide who should receive the product.
  3. Ask how treatment benefit will be assessed. The monitoring tests are not described by the label as the measure of benefit.
  4. Ask when follow-up occurs and who reviews the results.

Takeaway: A marker on a monitoring plan answers a safety question. Whether treatment is helping needs its own measure.

Appointment question: “What are we measuring for safety, what tells us whether treatment is helping, and when will we review both?”

Glucose explainer →IGF-1 explainer →Appointment worksheet →

Sources and review status

General education only. Bring your report, symptoms, and medication list to a qualified healthcare professional for advice about your care. Follow instructions from your lab or clinician if a result is marked critical.